[HTML][HTML] Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa …
I Lopez-Montesinos, MM Montero, S Domene-Ochoa… - Antibiotics, 2022 - mdpi.com
This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P.
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …
aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in …
[PDF][PDF] Anti-Infective Dosing Protocol/Policy MP01 Attachment Update: Ceftolozane-Tazobactam (C/T, Zerbaxa®)
S Bergman - unmc.edu
Anti-Infective Dosing Protocol/Policy MP01 Attachment Update: Ceftolozane- Tazobactam (C/T,
Zerbaxa ) Page 1 Anti-Infective Dosing Protocol/Policy MP01 Attachment Update …
Zerbaxa ) Page 1 Anti-Infective Dosing Protocol/Policy MP01 Attachment Update …